Discontinued — last reported Q4 '25
Johnson & Johnson Accounts Receivable decreased by 1.3% to $17.61B in Q3 2025 compared to the prior quarter. Year-over-year, this metric grew by 8.9%, from $16.17B to $17.61B. Over 3 years (FY 2021 to FY 2024), Accounts Receivable shows relatively stable performance with a -0.2% CAGR.
An increase relative to revenue may signal slowing collections or aggressive sales terms; a decrease suggests efficient billing and collection cycles.
The total amount of credit extended to customers for products and services already delivered, adjusted for potential bad...
Enterprise-focused peers like Oracle or SAP show similar patterns based on quarterly sales cycles.
accounts_receivable_net| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $14.94B | $14.87B | $14.91B | $15.28B | $15.59B | $16.14B | $16.16B | $16.35B | $14.80B | $14.87B | $14.95B | $15.79B | $16.17B | $14.84B | $16.02B | $17.85B | $17.61B |
| QoQ Change | — | -0.4% | +0.3% | +2.5% | +2.0% | +3.5% | +0.1% | +1.2% | -9.5% | +0.5% | +0.5% | +5.7% | +2.4% | -8.2% | +7.9% | +11.4% | -1.3% |
| YoY Change | — | — | — | — | +4.4% | +8.5% | +8.4% | +4.8% | -8.3% | -8.0% | — | -3.4% | +9.3% | -0.2% | +7.2% | +13.0% | +8.9% |
We use cookies for analytics. See our Privacy and Cookie Policy.